{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:35:28Z","timestamp":1790998528919,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.bone.2004.10.006","type":"journal-article","created":{"date-parts":[[2004,12,6]],"date-time":"2004-12-06T19:55:45Z","timestamp":1102362945000},"page":"150-158","source":"Crossref","is-referenced-by-count":73,"title":["Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse"],"prefix":"10.1016","volume":"36","author":[{"given":"Barbara M.","family":"Misof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Roschger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen L.","family":"Raggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Zraick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Root","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele L.","family":"Boskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Klaushofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fratzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy P.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2004.10.006_bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archinte.161.3.353","article-title":"Risedronate: a clinical review","volume":"161","author":"Crandall","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bone.2004.10.006_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00002512-200017040-00007","article-title":"Preventing fractures in postmenopausal women with osteoporosis. A review of recent controlled trials of antiresorptive agents","volume":"17","author":"Hochberg","year":"2000","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bone.2004.10.006_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1517\/14656566.1.2.225","article-title":"Bisphosphonates in osteoporosis: recent clinical experience","volume":"1","author":"McClung","year":"2000","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bone.2004.10.006_bib4","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1210\/jcem.85.11.6953","article-title":"Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group","volume":"85","author":"Black","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2004.10.006_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/15246090050118125","article-title":"Alendronate in the treatment of osteoporosis: a review of the clinical trials","volume":"9","author":"Siris","year":"2000","journal-title":"J. Women's Health Gend.-Based Med."},{"key":"10.1016\/j.bone.2004.10.006_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00001433-200010000-00003","article-title":"Osteogenesis Imperfecta","volume":"11","author":"Camacho","year":"2000","journal-title":"Curr. Opin. Orthop."},{"key":"10.1016\/j.bone.2004.10.006_bib7","series-title":"Metabolic bone disease and clinically related disorders","first-page":"651","article-title":"Osteogenesis Imperfecta","author":"Rowe","year":"1998"},{"key":"10.1016\/j.bone.2004.10.006_bib8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9","article-title":"Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels","volume":"9","author":"Kuivaniemi","year":"1997","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bone.2004.10.006_bib9","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1016\/S0021-9258(18)90635-6","article-title":"Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation","volume":"259","author":"Pihlajaniemi","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2004.10.006_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S8756-3282(00)00269-6","article-title":"Static and dynamic bone histomorphometry in children with osteogenesis imperfecta","volume":"26","author":"Rauch","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.10.006_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s002239900600","article-title":"The mineralization density of iliac crest bone from children with osteogenesis imperfecta","volume":"64","author":"Boyde","year":"1999","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2004.10.006_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s002239900571","article-title":"The microscopic structure of bone in normal children and patients with osteogenesis imperfecta: a survey using backscattered electron imaging","volume":"64","author":"Jones","year":"1999","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2004.10.006_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0945-053X(94)90200-3","article-title":"Ultrastructural studies of bones from patients with osteogenesis imperfecta","volume":"14","author":"Traub","year":"1994","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bone.2004.10.006_bib14","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0030-5898(20)31269-4","article-title":"The treatment of osteogenesis imperfecta","volume":"15","author":"Root","year":"1984","journal-title":"Orthop. Clin. North Am."},{"key":"10.1016\/j.bone.2004.10.006_bib15","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2004.10.006_bib16","first-page":"1846","article-title":"Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age","volume":"85","author":"Plotkin","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2004.10.006_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s002230010045","article-title":"A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta","volume":"69","author":"Camacho","year":"2001","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2004.10.006_bib18","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1073\/pnas.90.5.1701","article-title":"Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta","volume":"90","author":"Chipman","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2004.10.006_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/jmg.21.4.257","article-title":"The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta","volume":"21","author":"Nicholls","year":"1984","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bone.2004.10.006_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/jmbi.1997.1106","article-title":"Altered collagen structure in mouse tail tendon lacking the alpha 2(I)chain","volume":"270","author":"McBride","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bone.2004.10.006_bib21","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0022-2836(02)00703-9","article-title":"The role of the alpha2 chain in the stabilization of the collagen type I heterotrimer: a study of the type I homotrimer in oim mouse tissues","volume":"321","author":"Miles","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bone.2004.10.006_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1172\/JCI119519","article-title":"Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress","volume":"100","author":"Misof","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2004.10.006_bib23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1359\/jbmr.1999.14.2.264","article-title":"The material basis for reduced mechanical properties in oim mice bones","volume":"14","author":"Camacho","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.10.006_bib24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI118428","article-title":"Bone mineralization in an osteogenesis imperfecta mouse model studied by small angle X-ray scattering","volume":"97","author":"Fratzl","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2004.10.006_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/03008209609029199","article-title":"Mineral changes in a mouse model of osteogenesis imperfecta detected by Fourier transform infrared microscopy","volume":"35","author":"Camacho","year":"1996","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.bone.2004.10.006_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S8756-3282(01)00594-4","article-title":"Age and genotype dependence of bone material properties in the osteogenesis imperfecta murine model (oim)","volume":"29","author":"Grabner","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.10.006_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/03008200009005292","article-title":"Exploring the effects of hypermineralisation in bone tissue by using an extreme biological example","volume":"41","author":"Zioupos","year":"2000","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.bone.2004.10.006_bib28","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1242\/jeb.202.23.3285","article-title":"The design of mineralised hard tissues for their mechanical functions","volume":"202","author":"Currey","year":"1999","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.bone.2004.10.006_bib29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1098\/rstb.1984.0042","article-title":"Effects of differences in mineralization on the mechanical properties of bone","volume":"304","author":"Currey","year":"1984","journal-title":"Philos. Trans. R. Soc. Lond., B Biol. Sci."},{"key":"10.1016\/j.bone.2004.10.006_bib30","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0021-9290(97)00088-2","article-title":"Type I collagen mutation alters the strength and fatigue behavior of Mov13 cortical tissue","volume":"30","author":"Jepsen","year":"1997","journal-title":"J. Biomech."},{"key":"10.1016\/j.bone.2004.10.006_bib31","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1359\/jbmr.2001.16.10.1854","article-title":"Bone brittleness varies with genetic background in A\/J and C57BL\/6J inbred mice","volume":"16","author":"Jepsen","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.10.006_bib32","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1203\/00006450-200211000-00010","article-title":"Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model","volume":"52","author":"McCarthy","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bone.2004.10.006_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S8756-3282(00)00284-2","article-title":"Does suppression of bone turnover impair mechanical properties by allowing microdamage accumulation?","volume":"27","author":"Hirano","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.10.006_bib34","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","article-title":"Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib","volume":"15","author":"Mashiba","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.10.006_bib35","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","article-title":"Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles","volume":"28","author":"Mashiba","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.10.006_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(00)00301-X","article-title":"How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis?","volume":"27","author":"Delmas","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.10.006_bib37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1359\/jbmr.2000.15.4.621","article-title":"True strength","volume":"15","author":"Weinstein","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.10.006_bib38","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S8756-3282(00)00376-8","article-title":"Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women","volume":"27","author":"Boivin","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.10.006_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S8756-3282(01)00485-9","article-title":"Alendronate increases the degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women","volume":"29","author":"Roschger","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.10.006_bib40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/geno.1994.1141","article-title":"Confirmation of a G nucleotide deletion in the Cola-2 gene of mice with the osteogenesis imperfecta mutation","volume":"20","author":"McBride","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.bone.2004.10.006_bib41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jor.1100160107","article-title":"Identification of the oim mutation by dye terminator chemistry combined with automated direct DNA sequencing","volume":"16","author":"Camacho","year":"1998","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bone.2004.10.006_bib42","series-title":"Formulas for stress and strain","first-page":"292","author":"Roark","year":"1975"},{"key":"10.1016\/j.bone.2004.10.006_bib43","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","article-title":"Basic biomechanical measurements of bone: a tutorial","volume":"14","author":"Turner","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.10.006_bib44","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.10.006_bib45","first-page":"75","article-title":"A new scanning electron microscopy approach to the quantification of bone mineral distribution: backscattered electron image grey-levels correlated to calcium K alpha-line intensities","volume":"9","author":"Roschger","year":"1995","journal-title":"Scanning Microsc."},{"key":"10.1016\/j.bone.2004.10.006_bib46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S8756-3282(98)00112-4","article-title":"Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies","volume":"23","author":"Roschger","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.10.006_bib47","series-title":"Biostatistical analysis","first-page":"260","author":"Zar","year":"1999"},{"key":"10.1016\/j.bone.2004.10.006_bib48","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1172\/JCI0215952","article-title":"The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta","volume":"110","author":"Rauch","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2004.10.006_bib49","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1359\/jbmr.2003.18.4.610","article-title":"Bone mass, size and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy","volume":"18","author":"Rauch","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.10.006_bib50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00223-001-1055-5","article-title":"The effect of intravenous pamidronate on bone mineral density, bone histomorphometry, and parameters of bone turnover in adults with type IA osteogenesis imperfecta","volume":"72","author":"Shapiro","year":"2003","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2004.10.006_bib51","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1359\/jbmr.2003.18.1.126","article-title":"Intravenous neridronate in adults with osteogenesis imperfecta","volume":"18","author":"Adami","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.10.006_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00223001096","article-title":"Effects of estrogen and progesterone on tibia histomorphometry in growing rats","volume":"67","author":"Schmidt","year":"2000","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2004.10.006_bib53","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1359\/jbmr.2003.18.5.852","article-title":"Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmacokinetic analysis in rats","volume":"18","author":"Capparelli","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.10.006_bib54","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00223-002-1038-1","article-title":"Fourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim\/oim mice","volume":"72","author":"Camacho","year":"2003","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2004.10.006_bib55","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S8756-3282(97)00018-5","article-title":"Mineralization of cancellous bone after alendronate and sodium fluoride treatment: a quantitative backscattered electron imaging study on minipig ribs","volume":"20","author":"Roschger","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.10.006_bib56","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/ajkd.2002.31409","article-title":"Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodalysis patients","volume":"39","author":"Haas","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2004.10.006_bib57","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1359\/jbmr.040127","article-title":"Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy","volume":"19","author":"Cundy","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2004.10.006_bib58","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00431-003-1298-4","article-title":"The role of bisphosphonates in diseases of childhood","volume":"162","author":"Srivastava","year":"2003","journal-title":"Eur. J. Pediatr."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328204004211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328204004211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T13:44:25Z","timestamp":1625060665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328204004211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S8756328204004211"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2004.10.006","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}